Sanfilippo Syndrome synonyms

TL;DR: Sanfilippo Syndrome is medically classified as Mucopolysaccharidosis Type III (MPS III), a rare genetic metabolic disorder characterized by the body's inability to break down complex sugar molecules called heparan sulfate. While the term Sanfilippo Syndrome is most commonly used in clinical practice and by patient communities, it is officially categorized in medical literature as MPS III, encompassing four distinct subtypes (A, B, C, and D) based on the specific enzyme deficiency.

What are the different names for Sanfilippo Syndrome?

In medical records and scientific literature, you will frequently encounter the term Sanfilippo Syndrome alongside its formal classification, Mucopolysaccharidosis Type III (MPS III). The condition is named after Dr. Sylvester Sanfilippo, who first described the clinical features of the disease in 1963. Because the syndrome is a lysosomal storage disorder, it is also occasionally referred to as a "lysosomal storage disease." Patients and families may also see it categorized by its specific enzyme deficiency, such as "MPS IIIA" or "MPS IIIB," which helps clinicians distinguish between the four genetic subtypes of Sanfilippo Syndrome.

Why are there multiple names for this condition?

The variety of names for Sanfilippo Syndrome stems from the evolution of medical nomenclature. Historically, researchers named syndromes after the physician who first documented the constellation of symptoms. As our understanding of genetics and biochemistry progressed, the medical community shifted toward classification systems based on the underlying physiological cause—in this case, the accumulation of mucopolysaccharides. The "MPS III" designation is part of a broader group of disorders known as Mucopolysaccharidoses, which helps researchers group similar metabolic conditions together for study and treatment development.

How is Sanfilippo Syndrome classified in official databases?

Standardized medical systems use specific identifiers to ensure consistency in research and clinical documentation. Below are the primary ways Sanfilippo Syndrome is classified internationally:

• ICD-10/11: Classified under "Mucopolysaccharidosis, type III" (ICD-10 code E76.2).


• OMIM (Online Mendelian Inheritance in Man): Listed under multiple entries, specifically #252900 for MPS IIIA, #252920 for MPS IIIB, #252930 for MPS IIIC, and #252940 for MPS IIID.


• Orphanet: Recognized as ORPHA792, where it is listed as a rare metabolic disease.


• NCI Thesaurus: Indexed as a lysosomal storage disease with progressive neurodegeneration.

Which name should I use when talking to doctors?

While Sanfilippo Syndrome is widely recognized by pediatricians, neurologists, and geneticists, using the term "Mucopolysaccharidosis Type III" or "MPS III" is helpful for precise communication, especially when discussing specific subtypes. If you are communicating with specialists, providing the specific subtype (e.g., MPS IIIA) is essential, as clinical trials for gene therapy and enzyme replacement are often specific to one of the four types. Currently, 114 members of the DiseaseMaps.org community have shared their experiences with this condition, highlighting the importance of using clear, specific terminology when navigating care pathways.

Next steps

• Consult a metabolic geneticist to confirm your specific subtype (A, B, C, or D).


• Request a copy of your genetic testing report to keep in your medical file, as it contains the precise mutation information required for clinical trial eligibility.


• Join the DiseaseMaps.org community to connect with other families navigating the same diagnosis.


• Review the latest clinical trial updates on the Team Sanfilippo Foundation website or ClinicalTrials.gov.

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.

References

• National Institutes of Health (NIH) Genetic and Rare Diseases Information Center (GARD): rarediseases.info.nih.gov


• Orphanet: The portal for rare diseases and orphan drugs: orpha.net


• Online Mendelian Inheritance in Man (OMIM): omim.org


• Team Sanfilippo Foundation: teamsanfilippo.org